To view this email as a web page, click here.
November 15, 2018
 
Treatments for Actinic Keratosis
 
Dermatology Times
Demand for actinic keratosis treatments rise, while reimbursements shrink
Reimbursements for actinic keratosis treatments are down slightly, but the demand for treatment is up by 20 percent.
 
Patients not satisfied with photodynamic therapy for actinic keratosis
Literature review shows that laser-assisted photodynamic therapy more efficacious than photodynamic therapy alone for actinic keratosis.
 
Off-label uses for fluorouracil cream not always based on strong evidence
Topical 5‐fluorouracil is FDA-approved to treat actinic keratoses and superficial basal cell carcinoma, but it is commonly used off-label to treat a number of other skin conditions, such as squamous cell carcinoma despite strong evidence.
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.